Study refusal and exclusion from a randomized treatment study of generalized social phobia
Related Experiment Video
Updated: Aug 30, 2026

Social Threat-Safety Test Uncovers Psychosocial Stress-Related Phenotypes
Published on: December 15, 2023
Jonathan D Huppert1, Martin E Franklin, Edna B Foa
1Center for the Treatment and Study of Anxiety, University of Pennsylvania, Philadelphia, PA 19104, USA. huppert@mail.med.upenn.edu
Abstract:
We examine treatment exclusion and refusal rates as well as reasons for non-participation in a sub-sample of phone interviews conducted to determine eligibility for a randomized study of treatments for generalized social phobia (GSP). This study compared group comprehensive cognitive behavioral therapy (CCBT) to fluoxetine (FLU), placebo (PLA), or their combination. Results suggest that the major exclusion for the study was due to comorbid depression, followed by having a different diagnosis as primary. Patient refusal to enter the study was also common, with the most frequently reported reason being not wanting to take medication. Notably, few people who refused stated an objection to entering CCBT or PLA. These results suggest that there is a need to develop and evaluate a treatment for social anxiety with comorbid depression and to systematically study reasons for reluctance to take medication among individuals with GSP.
Related Concept Videos
Blinding
Blind Procedures
Social Anxiety Disorder
Ethics in Research
Randomized Experiments
Simple randomization
Simple...
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
